Test Bank for Pharmacology a Patient-Centered Nursing Process Approach, 12th Edition by McCuistion, DiMaggio, Winton, and Yeager

Pharmacology is the science that stands between your patient and harm.

Every drug you give carries a therapeutic promise and a potential risk. Every dose calculation, every adverse effect you catch, and every patient education moment is an expression of your pharmacological competence. In nursing there is no passive role in medication management. You are not just a delivery mechanism for a prescription. You are an independent clinical thinker and the last checkpoint between the drug and the patient.

That responsibility demands preparation that goes well beyond memorizing drug names and side effect lists.

This test bank accompanies the 12th Edition of Pharmacology: A Patient-Centered Nursing Process Approach by McCuistion, DiMaggio, Winton, and Yeager, a widely used and respected pharmacology text in undergraduate nursing education. It gives you focused, patient-centered, nursing-process-driven practice for every chapter, turning pharmacology knowledge into medication safety competence in the classroom, on the NCLEX, and at the bedside.

Table of Contents

UNIT I: Introduction to Pharmacology

1. Clinical Judgment Measurement Model and the Nursing Process
2. Drug Development and Ethical Considerations
3. Pharmacokinetics and Pharmacodynamics
4. Pharmacogenetics
5. Complementary and Alternative Therapies
6. Pediatric Considerations
7. Geriatric Considerations
8. Drugs in Substance Use Disorder

UNIT II: Pharmacotherapy and Drug Administration
9. Safety and Quality
10. Drug Administration
11. Drug Labels and Dosage Calculations

UNIT III: Maintenance of Homeostasis
12. Fluid Volume and Electrolytes
13. Vitamin and Mineral Replacement
14. Nutritional Support

UNIT IV: Autonomic Nervous System Drugs
15. Adrenergic Agonists and Antagonists
16. Cholinergic Agonists and Antagonists

NIT V: Central and Peripheral Nervous System Drugs
17. Stimulants
18. Depressants
19. Antiseizure Drugs
20. Drugs for Parkinsonism and Alzheimer’s Disease
21. Drugs for Neuromuscular Disorders and Muscle Spasms

UNIT VI: Mental and Behavioral Health Drugs
22. Antipsychotics and Anxiolytics
23. Antidepressants and Mood Stabilizers

UNIT VII: Pain and Inflammation Management Drugs
24. Antiinflammatories
25. Analgesics

UNIT VIII: Antimicrobial Drugs
26. Penicillins, Other Beta-Lactams, and Cephalosporins
27. Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, and Lipopeptides
28. Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones
29. Sulfonamides and Nitroimidazoles Antibiotics
30. Antituberculars, Antifungals, and Antivirals
31. Antimalarials, Anthelmintics, and Peptides

UNIT IX: Immunologic Drugs
32. HIV- and AIDS-Related Drugs
33. Transplant Drugs
34. Vaccines

UNIT X: Antineoplastics and Biologic Response Modifiers
35. Anticancer Drugs
36. Targeted Therapies to Treat Cancer
37. Biologic Response Modifiers

UNIT XI: Respiratory Drugs
38. Upper Respiratory Disorders
39. Lower Respiratory Disorders

UNIT XII: Cardiovascular Drugs
40. Cardiac Glycosides, Antianginals, and Antidysrhythmics
41. Diuretics
42. Antihypertensives
43. Anticoagulants, Antiplatelets, and Thrombolytics
44. Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow

UNIT XIII: Gastrointestinal Drugs
45. Gastrointestinal Tract Disorders
46. Antiulcer Drugs

UNIT XIV: Eye, Ear, and Skin Drugs
47. Eye and Ear Disorders
48. Dermatologic Disorders

UNIT XV: Endocrine Drugs
49. Pituitary, Thyroid, Parathyroid, and Adrenal Disorders
50. Antidiabetics

UNIT XVI: Renal and Urologic Drugs
51. Urinary Disorders

UNIT XVII: Reproductive and Gender-Related Drugs
52. Pregnancy and Preterm Labor
53. Labor, Delivery, and Postpartum
54. Neonatal and Newborn
55. Women’s Reproductive Health
56. Men’s Reproductive Disorders
57. Sexually Transmitted Infections

UNIT XVIII: Emergency Drugs
58. Adult and Pediatric Emergency Drugs

What’s Inside

• Hundreds of practice questions covering every chapter
• Multiple-choice, select-all-that-apply, alternate-format, and Next Generation NCLEX-style scenario questions
• Complete answer keys with clinically grounded pharmacological rationales
• Alignment with current NCLEX-RN, NCLEX-PN, and Next Generation NCLEX standards
• Coverage of major drug classifications, nursing implications, patient education priorities, and medication safety across every body system

Who It’s For

• Undergraduate RN and LPN students in pharmacology courses using the 12th Edition
• NCLEX-RN and NCLEX-PN candidates reviewing pharmacology
• Students preparing for ATI pharmacology proctored assessments
• Nursing faculty writing pharmacology exams and unit assessments
• LPN-to-RN bridge students
• Accelerated BSN and second-degree students
• New graduate nurses reinforcing medication safety and drug therapy knowledge

Topics Covered

• Principles of pharmacokinetics: absorption, distribution, metabolism, and excretion
• Pharmacodynamics: drug-receptor interactions, dose-response relationships, and drug potency
• Drug interactions, adverse drug reactions, and medication safety principles
• The nursing process applied to pharmacological care
• Patient education, health literacy, and medication adherence strategies
• Lifespan pharmacology: pediatric, geriatric, and pregnancy considerations
• Cultural and genetic influences on pharmacotherapy
• Analgesics: opioid agonists, partial agonists, antagonists, and non-opioid agents
• Anti-inflammatory agents: NSAIDs, corticosteroids, and DMARDs
• Antibiotics: penicillins, cephalosporins, tetracyclines, fluoroquinolones, and macrolides
• Antivirals, antifungals, antiprotozoals, and antiretroviral therapy
• Cardiovascular drugs: antihypertensives, antidysrhythmics, and heart failure agents
• Anticoagulants, antiplatelets, and thrombolytic therapy
• Diuretics and renal pharmacotherapy
• Central nervous system drugs: antidepressants, antipsychotics, anxiolytics, and mood stabilizers
• Antiepileptic drugs and neurological pharmacotherapy
• Endocrine pharmacotherapy: insulin, oral antidiabetics, thyroid, and adrenal agents
• Respiratory pharmacotherapy: bronchodilators, corticosteroids, and antihistamines
• Gastrointestinal pharmacotherapy: antacids, antiemetics, and bowel agents
• Oncology pharmacotherapy principles and biotherapy
• Immunological agents: vaccines, immunosuppressants, and biologics
• Reproductive and women’s health pharmacotherapy
• Vitamins, minerals, herbal products, and dietary supplement considerations

Why This Test Bank Delivers Results

The 12th Edition of McCuistion, DiMaggio, Winton, and Yeager reflects recent FDA approvals, current clinical guidelines, updated black box warning communications, and the Next Generation NCLEX clinical judgment framework. It integrates the nursing process deeply, so it works as a clinical decision-making guide that teaches you how to think about medications, not just what to know about them. This test bank is built to match that approach.

Every question reflects the patient-centered nursing process. You won’t just identify what a drug does. You’ll apply the nursing process to a real patient receiving it. You’ll assess before the first dose, identify the priority nursing diagnosis that guides monitoring, implement safe administration, evaluate whether therapy is achieving its intended outcome, and educate the patient in language that promotes safety and adherence.

The NGN-style scenario questions walk you through the six cognitive processes of the Clinical Judgment Measurement Model (recognize cues, analyze cues, prioritize hypotheses, generate solutions, take actions, and evaluate outcomes) in a pharmacological context.

Rationales explain the pharmacological mechanisms, nursing process applications, safety principles, and clinical reasoning behind each answer, and reflect the 12th Edition’s drug therapy updates. Questions are organized chapter by chapter, so you can target the drug classes where you’re weakest and return to high-yield categories as your exam approaches.

Sample Questions

Question 1
A nurse is preparing to give IV digoxin 0.25 mg to a patient with newly diagnosed heart failure and atrial fibrillation. The nurse finds an apical pulse of 52 beats per minute and a blood pressure of 108/68 mmHg. The patient reports seeing yellow-green halos around lights and has felt nauseated since yesterday. This morning’s serum digoxin level is 2.4 ng/mL. Which action is most appropriate?

A) Give the digoxin as prescribed, since the dose is standard for heart failure
B) Hold this dose, withhold only the next scheduled dose, and document the findings
C) Hold the digoxin, notify the provider urgently, obtain an ECG, and check serum electrolytes
D) Give half the prescribed dose and reassess the apical pulse and vision symptoms in two hours

Correct answer: C
Rationale: This patient shows several signs of digoxin toxicity. The level of 2.4 ng/mL is above the commonly cited therapeutic range of 0.5–2.0 ng/mL (current practice often targets 0.5–0.9 ng/mL in heart failure), the apical pulse is below the usual hold parameter of 60 bpm, and the visual disturbances and nausea are classic toxicity symptoms. Digoxin toxicity can cause heart block, junctional rhythms, and ventricular dysrhythmias, so an ECG is essential. Potassium and magnesium must be checked because hypokalemia increases digoxin binding to myocardial Na⁺/K⁺-ATPase and potentiates toxicity. Giving any dose, full or partial, to a patient with these findings is a serious medication error. Withholding only one dose and simply documenting would delay the evaluation and treatment of possible toxicity.

Question 2
A nursing student is completing a pharmacology case study on a 72-year-old patient newly prescribed warfarin 5 mg daily for pulmonary embolism. The patient also takes levothyroxine and omeprazole and has just started fluconazole for a fungal infection. Which interaction poses the greatest immediate safety risk?

A) Warfarin and levothyroxine, increasing sensitivity to anticoagulation
B) Warfarin and omeprazole, reducing warfarin absorption and anticoagulant effect
C) Warfarin and fluconazole, with CYP2C9 inhibition raising warfarin levels and bleeding risk
D) Warfarin and levothyroxine, causing thyroid hormone displacement and metabolic rate changes

Correct answer: C
Rationale: Fluconazole inhibits CYP2C9, the main enzyme that metabolizes the more potent S-enantiomer of warfarin. Reduced clearance causes warfarin to accumulate, producing a markedly elevated INR and a substantially higher risk of serious bleeding. The INR can rise sharply within days of starting fluconazole, so the provider should be notified promptly, INR monitoring increased, and a warfarin dose reduction or alternative antifungal considered. Levothyroxine does interact with warfarin, because thyroid hormone increases the catabolism of vitamin K-dependent clotting factors and enhances the anticoagulant effect, but the effect develops more gradually and is generally smaller. Omeprazole has a modest effect on warfarin, and it does not reduce its absorption in a clinically significant way. Option D does not describe a recognized interaction mechanism.

Question 3
A nurse is caring for a 68-year-old with type 2 diabetes who has taken glipizide, a sulfonylurea, for five years. The patient is NPO after midnight for a non-cardiac procedure. At 0700 the blood glucose is 64 mg/dL, and the patient is diaphoretic, tremulous, and confused. Which sequence of actions is most appropriate?

A) Give the morning glipizide as scheduled and offer orange juice with it
B) Hold the glipizide, give 15–20 g of fast-acting oral carbohydrate if the patient can swallow safely, recheck glucose in 15 minutes, and notify the provider
C) Hold the glipizide, give IV dextrose 50% immediately, and transfer to the ICU for continuous glucose monitoring
D) Give glucagon 1 mg subcutaneously and hold the glipizide until glucose normalizes

Correct answer: B
Rationale: This is symptomatic hypoglycemia, likely from the sulfonylurea in an NPO patient. Sulfonylureas stimulate insulin secretion regardless of food intake, so the risk rises when the patient isn’t eating. Treatment follows the 15-15 rule: hold the causative drug, give 15–20 g of fast-acting carbohydrate if the patient can swallow safely, recheck in 15 minutes, repeat if glucose remains below 70 mg/dL, and notify the provider. The confusion needs a swallowing check first, and if the patient can’t swallow safely or has a decreased level of consciousness, the nurse should move to IV dextrose or glucagon per protocol. IV dextrose 50% and ICU transfer are not first steps in a conscious patient who can swallow. Glucagon is for severe hypoglycemia when oral intake and IV access aren’t available. Giving glipizide to an NPO patient with hypoglycemia would be a dangerous error. Because sulfonylurea hypoglycemia can recur, the patient needs ongoing glucose monitoring.

Question 4
A nurse is teaching a 45-year-old who has just been prescribed sertraline 50 mg daily for major depressive disorder. The patient asks when they can expect to feel better. Which response is most accurate?

A) “Most patients feel completely better within the first three to five days.”
B) “Sertraline works immediately, so you should notice a big improvement by tomorrow.”
C) “Full antidepressant effect usually takes two to four weeks or longer. You may notice sleep and appetite improve first, with mood following over several weeks.”
D) “If it doesn’t work within one week, stop taking it and ask your provider for a different medication.”

Correct answer: C
Rationale: SSRIs have a therapeutic lag, with full effect often taking four to six weeks or longer, although some improvement can appear within the first two weeks. The delay is attributed to gradual neuroadaptive changes in serotonin receptors and downstream signaling rather than an immediate rise in serotonin. Patients often notice improvement in sleep, appetite, and energy before mood lifts. Setting this expectation helps prevent premature discontinuation, a common cause of treatment failure. Options A and B create false expectations and can lead to disappointment and nonadherence. Option D encourages self-discontinuation, and stopping an SSRI abruptly can cause discontinuation syndrome and relapse. The nurse should also remind the patient to report worsening mood or suicidal thoughts, especially in the early weeks.

Question 5
A nurse is reviewing the history of a 78-year-old with chronic insomnia who has taken diphenhydramine 50 mg nightly for six months. The patient says it no longer helps and asks for something stronger. Which response best applies the nursing process and current medication safety principles?

A) Suggest doubling the diphenhydramine dose because the patient has developed tolerance
B) Recommend switching to a benzodiazepine such as temazepam for more reliable sedation
C) Explain the risks of anticholinergic drugs in older adults, assess for cognitive and urinary side effects, recommend non-pharmacological sleep strategies, and encourage a provider consultation about safer alternatives
D) Reassure the patient that diphenhydramine is safe for long-term use in older adults and tolerance is the only concern

Correct answer: C
Rationale: Diphenhydramine is a first-generation anticholinergic antihistamine, and the AGS Beers Criteria list it as a potentially inappropriate medication in older adults. Its anticholinergic effects include confusion, falls, urinary retention, constipation, and sometimes paradoxical agitation, and long-term anticholinergic use has been associated with a higher risk of delirium and possibly dementia. The patient’s loss of sedative effect shows the drug isn’t meeting its goal. The nurse should assess for existing side effects, teach about the risks at this age, reinforce sleep hygiene and cognitive behavioral therapy for insomnia, and involve the provider, who might consider alternatives such as low-dose doxepin. Doubling the dose increases anticholinergic exposure. Benzodiazepines are also on the Beers list because of fall and cognitive risks.

Frequently Asked Questions

Which edition does this test bank cover?
The 12th Edition of Pharmacology: A Patient-Centered Nursing Process Approach by McCuistion, DiMaggio, Winton, and Yeager. Questions follow that edition’s chapter organization, updated drug content, current FDA safety communications, NGN integration, and evidence-based nursing pharmacology standards.

How is it different from the 11th Edition test bank?
It is written specifically for the 12th Edition, which includes updated drug therapy guidelines, new FDA approvals and safety communications, expanded NGN clinical judgment content, and a revised chapter organization compared with the 11th. Students using the 12th Edition should use this test bank for edition-specific preparation.

How are the questions organized?
Chapter by chapter. You can study all of the pharmacological content in order or focus on drug classes such as cardiovascular agents, anti-infectives, or CNS medications. The nursing process framework runs through every chapter’s question set.

Is it aligned with the NCLEX and Next Generation NCLEX?
Yes. Questions reflect current NCLEX-RN and NCLEX-PN standards and the clinical judgment emphasis of the NGN, with scenarios that ask you to recognize cues, prioritize hypotheses, and evaluate outcomes in medication-related patient care.

Is it useful for both RN and LPN students?
Yes. Pharmacology and parenteral therapies are heavily tested on both the NCLEX-RN and NCLEX-PN, and the test bank covers the pharmacokinetics, drug classification, nursing implications, and patient education content that LPN courses and licensing exams require.

How soon can I access it?
Immediately. You get instant digital access after purchase and can study on any device, on your own schedule.

Are the rationales detailed enough for real learning?
Yes. Each rationale explains the pharmacological mechanism, nursing process application, safety principles, and clinical reasoning behind the correct answer, not just which option is right.

Can faculty use it for course assessments?
Yes. The chapter-by-chapter organization, NGN-style formats, nursing process integration, and scenario emphasis suit unit exams, ATI-style proctored assessments, and comprehensive finals in RN and PN pharmacology courses.